Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes

Pathological cardiac hypertrophy, the adaptive response of the myocardium to various pathological stimuli, is one of the primary predictors and predisposing factors of heart failure. However, its molecular mechanisms underlying pathogenesis remain poorly understood. Here, we studied the function of...

Full description

Bibliographic Details
Main Authors: Ran Xu, Le Kang, Siang Wei, Chunjie Yang, Yuanfeng Fu, Zhiwen Ding, Yunzeng Zou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.748156/full
_version_ 1818361125579784192
author Ran Xu
Le Kang
Siang Wei
Chunjie Yang
Yuanfeng Fu
Zhiwen Ding
Yunzeng Zou
author_facet Ran Xu
Le Kang
Siang Wei
Chunjie Yang
Yuanfeng Fu
Zhiwen Ding
Yunzeng Zou
author_sort Ran Xu
collection DOAJ
description Pathological cardiac hypertrophy, the adaptive response of the myocardium to various pathological stimuli, is one of the primary predictors and predisposing factors of heart failure. However, its molecular mechanisms underlying pathogenesis remain poorly understood. Here, we studied the function of Samm50 in mitophagy during Ang II-induced cardiomyocyte hypertrophy via lentiviruses mediated knockdown and overexpression of Samm50 protein. We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. Then, Samm50 overexpression exhibits enhanced induction of cardiac hypertrophy marker genes and cell enlargement in primary mouse cardiomyocytes by qPCR and immunofluorescence analysis, respectively. Meanwhile, Samm50 remarkably reduced Ang II-induced autophagy as indicated by decreased mitophagy protein levels and autophagic flux, whereas the opposite phenotype was observed in Samm50 knockdown cardiomyocytes. However, the protective role of Samm50 deficiency against cardiac hypertrophy was abolished by inhibiting mitophagy through Vps34 inhibitor or Pink1 knockdown. Moreover, we further demonstrated that Samm50 interacted with Pink1 and stimulated the accumulation of Parkin on mitochondria to initiate mitophagy by co-immunoprecipitation analysis and immunofluorescence. Thus, these results suggest that Samm50 regulates Pink1-Parkin-mediated mitophagy to promote cardiac hypertrophy, and targeting mitophagy may provide new insights into the treatment of cardiac hypertrophy.
first_indexed 2024-12-13T21:11:43Z
format Article
id doaj.art-20e0eb7c1bce40768dbce1ef56d43ecb
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-13T21:11:43Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-20e0eb7c1bce40768dbce1ef56d43ecb2022-12-21T23:31:20ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-09-01810.3389/fcvm.2021.748156748156Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal CardiomyocytesRan XuLe KangSiang WeiChunjie YangYuanfeng FuZhiwen DingYunzeng ZouPathological cardiac hypertrophy, the adaptive response of the myocardium to various pathological stimuli, is one of the primary predictors and predisposing factors of heart failure. However, its molecular mechanisms underlying pathogenesis remain poorly understood. Here, we studied the function of Samm50 in mitophagy during Ang II-induced cardiomyocyte hypertrophy via lentiviruses mediated knockdown and overexpression of Samm50 protein. We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. Then, Samm50 overexpression exhibits enhanced induction of cardiac hypertrophy marker genes and cell enlargement in primary mouse cardiomyocytes by qPCR and immunofluorescence analysis, respectively. Meanwhile, Samm50 remarkably reduced Ang II-induced autophagy as indicated by decreased mitophagy protein levels and autophagic flux, whereas the opposite phenotype was observed in Samm50 knockdown cardiomyocytes. However, the protective role of Samm50 deficiency against cardiac hypertrophy was abolished by inhibiting mitophagy through Vps34 inhibitor or Pink1 knockdown. Moreover, we further demonstrated that Samm50 interacted with Pink1 and stimulated the accumulation of Parkin on mitochondria to initiate mitophagy by co-immunoprecipitation analysis and immunofluorescence. Thus, these results suggest that Samm50 regulates Pink1-Parkin-mediated mitophagy to promote cardiac hypertrophy, and targeting mitophagy may provide new insights into the treatment of cardiac hypertrophy.https://www.frontiersin.org/articles/10.3389/fcvm.2021.748156/fullcardiac hypertrophymitophagySamm50Pink1heart failure
spellingShingle Ran Xu
Le Kang
Siang Wei
Chunjie Yang
Yuanfeng Fu
Zhiwen Ding
Yunzeng Zou
Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes
Frontiers in Cardiovascular Medicine
cardiac hypertrophy
mitophagy
Samm50
Pink1
heart failure
title Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes
title_full Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes
title_fullStr Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes
title_full_unstemmed Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes
title_short Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes
title_sort samm50 promotes hypertrophy by regulating pink1 dependent mitophagy signaling in neonatal cardiomyocytes
topic cardiac hypertrophy
mitophagy
Samm50
Pink1
heart failure
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.748156/full
work_keys_str_mv AT ranxu samm50promoteshypertrophybyregulatingpink1dependentmitophagysignalinginneonatalcardiomyocytes
AT lekang samm50promoteshypertrophybyregulatingpink1dependentmitophagysignalinginneonatalcardiomyocytes
AT siangwei samm50promoteshypertrophybyregulatingpink1dependentmitophagysignalinginneonatalcardiomyocytes
AT chunjieyang samm50promoteshypertrophybyregulatingpink1dependentmitophagysignalinginneonatalcardiomyocytes
AT yuanfengfu samm50promoteshypertrophybyregulatingpink1dependentmitophagysignalinginneonatalcardiomyocytes
AT zhiwending samm50promoteshypertrophybyregulatingpink1dependentmitophagysignalinginneonatalcardiomyocytes
AT yunzengzou samm50promoteshypertrophybyregulatingpink1dependentmitophagysignalinginneonatalcardiomyocytes